http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120125305-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
| filingDate | 2011-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20120125305-A |
| titleOfInvention | Alpha-2 adrenergic agonist with long-lasting hypotonic effect |
| abstract | The present invention provides a therapeutically effective amount of a pharmaceutical composition comprising 4-bromo-5- (2-imidazolin-2-ylamino) benzimidazole or a salt thereof as a single dose in a diseased eye of a patient. Including the administering, the method provides a drop in intraocular pressure wherein the affected eye has an intraocular pressure below baseline intraocular pressure for at least eight (8) hours. |
| priorityDate | 2010-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.